MYIDYL Drug Patent Profile
✉ Email this page to a colleague
When do Myidyl patents expire, and what generic alternatives are available?
Myidyl is a drug marketed by Usl Pharma and is included in one NDA.
The generic ingredient in MYIDYL is triprolidine hydrochloride. There are thirteen drug master file entries for this compound. Additional details are available on the triprolidine hydrochloride profile page.
Summary for MYIDYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 4,439 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MYIDYL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MYIDYL
US Patents and Regulatory Information for MYIDYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Usl Pharma | MYIDYL | triprolidine hydrochloride | SYRUP;ORAL | 087963-001 | Jan 18, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |